smartphone-diagnostics
(4)
Healthy.io
Healthy.io turns the smartphone camera into a clinical-grade medical device for at-home diagnostics. Founded in Israel in 2013 by Yonatan Adiri, the company uses computer vision, AI and colorimetric analysis to let patients run lab-quality urine tests at home - for kidney disease, urinary tract infections and pregnancy - and gives clinicians AI-powered 3D wound measurement tools. Its flagship Minuteful Kidney test is the first smartphone-powered home test cleared by the FDA to measure the albumin-to-creatinine ratio, and its products are used across US health plans and UK NHS trusts to close gaps in preventative care.
Ron Zohar
Ron Zohar is a co-founder and executive at Healthy.io, the Tel Aviv digital-health company that turns a smartphone camera into a clinical-grade medical device. He leads product and technology work behind Healthy.io's at-home urinalysis and wound-imaging platforms. A former Israeli Air Force officer with degrees in physics and philosophy from Tel Aviv University, he previously ran mobile product at Fiverr and co-founded Groovideo before helping build one of Israel's most-funded digital-health startups.
HueDx
HueDx is a Philadelphia diagnostics company - formerly Group K Diagnostics - that turns any smartphone camera into a reader for lab-grade, quantitative color-based tests. Its patented HueCard color-correction hardware and AI-powered HueTools/HueCloud software let researchers develop, validate, and deploy paper-based colorimetric assays without proprietary readers or lab infrastructure, aiming to make quantitative results available at the point of care and at home.
Brianna Wronko-Stevens
Brianna Wronko-Stevens is a University of Pennsylvania-trained bioengineer who turned a senior design project into HueDx (formerly Group K Diagnostics), a Philadelphia diagnostics company that reads lab-grade results off a color-changing card and a smartphone camera - no lab, no reader, no waiting days. Inspired by an HIV clinic internship at 17, she built a platform to deliver fast, quantitative results to the patients who can least afford to wait. She founded the company in 2017, served as CEO through a 2023 rebrand and raised millions in funding, then stepped into the Chief Scientific Officer seat to focus on the science.